文献速递神经肿瘤神经创伤

肿瘤与创伤性脑损伤患者定制多孔羟基磷灰石颅骨修补术:单中心病例系列

Custom-Made Porous Hydroxyapatite Cranioplasty in Patients with Tumor Versus Traumatic Brain Injury: A Single-Center Case Series.
PubMed 文献 · World Neurosurg · 2020-04-06

单中心连续纳入2003年3月至2018年5月间因肿瘤切除或创伤性脑损伤行定制多孔羟基磷灰石颅骨修补的患者,比较两组不良事件。肿瘤组38例、创伤组39例;肿瘤组84%为单期手术而创伤组为8%(P<0.0001),两组不良事件发生率无显著差异(P=0.4309)且与手术时机无关。作者认为定制羟基磷灰石颅骨修补是颅骨重建的一种解决方案,不良事件发生率低。

要点

  • 肿瘤组单期手术占84%,创伤组占8%,两组手术时机差异显著(P<0.0001)。
  • 两组不良事件发生率无显著差异(P=0.4309),且与手术时机无关。
  • 连续系列中创伤或肿瘤患者不良事件发生率均低,作者认为该假体是安全方案。

核心结论

  • 定制羟基磷灰石颅骨修补是颅骨肿瘤患者颅骨重建的一种解决方案。
  • 连续系列中创伤或肿瘤患者不良事件发生率均低,表明这些假体是独立于病例特征的安全解决方案。

研究设计与样本

  • 单中心连续病例系列,纳入2003年3月至2018年5月间因肿瘤切除和创伤性脑损伤后使用定制多孔羟基磷灰石植入物行颅骨修补的连续患者。
  • 植入物根据术者规格并基于通过标准化方案获得的患者计算机断层扫描数据设计和生产。
  • 收集并分析肿瘤组38例与创伤性脑损伤组39例患者的信息,记录不良事件。

主要发现

  • 肿瘤组单期手术占84%,创伤性脑损伤组占8%(P<0.0001)。
  • 两组不良事件发生率无显著差异(P=0.4309),且不良事件与手术时机无关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cranioplasty is a common neurosurgical procedure with the goal of restoring skull integrity. Custom-made porous hydroxyapatite prostheses have long been used for cranial reconstruction in patients with traumatic brain injury. We present a large consecutive series of 2 groups of patients undergoing cranioplasty with hydroxyapatite custom bone and compare the adverse events (AEs) between the 2 groups. METHODS: We examined a series of consecutive patients who underwent cranioplasty using custom-made porous hydroxyapatite implants following tumor resection and traumatic brain injury at a single center between March 2003 and May 2018. The implants were designed and produced according to the surgeon's specifications and based on the patient's computed tomography scan data obtained through a standardized protocol. AEs were recorded. RESULTS: Information on 38 patients with tumor and 39 patients with traumatic brain injury was collected and analyzed. A significant difference in the timing of surgery was found between the 2 groups; single-stage surgery was performed in 84% of patients in the tumor versus 8% of those in the traumatic brain injury group (P < 0.0001). The rate of AEs was not significantly different between the 2 groups (P = 0.4309) and was not related to the timing of surgery. CONCLUSIONS: Custom-made hydroxyapatite cranioplasty is a solution for cranial reconstruction in patients with cranial tumors. The low incidence of AEs in a consecutive series of patients with either trauma or tumors demonstrates that these prostheses represent a safe solution independent of the characteristics of cases.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Rossini Z, Franzini A, Zaed I, et al. Custom-Made Porous Hydroxyapatite Cranioplasty in Patients with Tumor Versus Traumatic Brain Injury: A Single-Center Case Series. World Neurosurg. 2020. PMID: 32272268. doi:10.1016/j.wneu.2020.03.144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。